Piotr Gluszko | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Best Researcher Award

Piotr Gluszko
National Institute of Geriatrics, Poland

Piotr Gluszko
Affiliation National Institute of Geriatrics
Country Poland
Scopus ID 6603791530
Documents 105
Citations 2,530
h-index 22
Subject Area Medicine and Dentistry
Event Global Scholar Awards
ORCID 0000-0001-5717-4472

The Best Researcher Award recognizes distinguished scholarly achievement, sustained scientific contributions, and measurable impact within a specialized academic discipline. Piotr Gluszko has established a notable research profile in medicine and dentistry through extensive publication activity, citation influence, and engagement in clinical and translational research initiatives. His academic record reflects continued contributions to evidence-based healthcare and rheumatology-related investigations, supporting advancements in patient care and scientific understanding.[1]

Abstract

Piotr Gluszko is a medical researcher associated with the National Institute of Geriatrics in Poland whose scholarly work has contributed to clinical medicine, rheumatology, musculoskeletal disorders, and evidence-based healthcare.[3] His publication portfolio demonstrates sustained engagement in research addressing diagnosis, treatment outcomes, patient management, and healthcare quality. With more than one hundred indexed documents and significant citation performance, his work has supported scientific communication and clinical advancement. The combination of publication productivity, research visibility, and academic influence highlights a professional record aligned with the standards commonly recognized through international academic distinctions and researcher excellence awards.[1][2]

Keywords

  • Rheumatology
  • Geriatric Medicine
  • Clinical Research
  • Musculoskeletal Disorders
  • Healthcare Outcomes
  • Evidence-Based Medicine
  • Patient Care
  • Inflammatory Diseases
  • Medical Research
  • Dentistry
  • Scientific Publications
  • Academic Impact

Introduction

Piotr Gluszko has contributed to medical science through investigations focused on rheumatology, patient care, and clinical outcomes. His research activities emphasize evidence-based approaches that support improved healthcare delivery and scientific understanding. Through collaborative studies and scholarly dissemination, he has maintained a visible presence within the international medical research community.[1]

Research Profile

Affiliated with the National Institute of Geriatrics, Piotr Gluszko has developed a substantial publication record comprising indexed articles, reviews, and collaborative studies. His scholarly metrics, including citations and h-index performance, reflect sustained academic engagement and recognition within medicine and dentistry-related research disciplines.[1]

Research Contributions

His contributions include advancing knowledge in rheumatic diseases, clinical management strategies, healthcare assessment, and treatment evaluation. Research outputs have supported scientific discussions regarding disease mechanisms, therapeutic effectiveness, and patient-centered care while contributing to broader clinical practice and medical education initiatives.[2]

Publications

The researcher has produced more than one hundred indexed publications spanning clinical medicine and rheumatology. These works include original investigations, collaborative studies, reviews, and scholarly communications that contribute to scientific literature and provide evidence supporting healthcare decision-making and future research development.[1]

Research Impact

Citation performance exceeding two thousand references indicates meaningful scholarly visibility and academic utilization. The influence of his research extends across clinical practice, scientific communication, and healthcare investigations, demonstrating relevance to researchers, clinicians, and institutions engaged in evidence-based medicine.[4]

Award Suitability

The combination of publication productivity, citation influence, recognized expertise, and sustained research engagement supports consideration for the Best Researcher Award. His scholarly achievements align with evaluation criteria emphasizing research quality, scientific contribution, academic visibility, and measurable impact within medicine and dentistry.[1]

Conclusion

Piotr Gluszko’s academic record demonstrates sustained commitment to medical research, publication excellence, and scientific advancement. His contributions, supported by strong bibliometric indicators and international visibility, represent qualities commonly associated with distinguished scholarly recognition and researcher achievement awards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Piotr Gluszko, Author ID 6603791530. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=6603791530

  2. Gluszko, P., et al. Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry.

    https://doi.org/10.1038/s41584-020-00526-0

  3. ORCID. (n.d.). Piotr Gluszko ORCID Record.

    https://orcid.org/0000-0001-5717-4472

  4. ResearchGate. (n.d.). ResearchGate profile of Piotr Gluszko.

    https://www.researchgate.net/profile/Piotr-Gluszko-2

Georgeta Zegan | Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Prof. Dr. Georgeta Zegan | Dentistry | Research Excellence Award

Professor | Grigore T. Popa University of Medicine and Pharmacy Iasi | Romania

Prof. Dr. Georgeta Zegan is a researcher affiliated with Universitatea de Medicină și Farmacie “Grigore T. Popa” Iași, Romania, specializing in medical sciences, dental research, and biomaterials for orthopedic applications. With 80 publications, 366 citations, and an h-index of 11, she has established a strong academic presence in interdisciplinary biomedical research. Her work spans dento-facial studies, biodegradable alloys, and healthcare quality, contributing to both clinical and material science advancements. Actively collaborating with an extensive network of researchers, her studies support innovation in patient care and medical technologies. Her contributions hold significant societal impact by improving healthcare outcomes, advancing biomaterials, and promoting evidence-based medical practices globally.

Citation Metrics (Scopus)

366
275
180
90
0

Citations

366

Documents

80

h-index

11

Citations

Documents

h-index

View Scopus Profile
 View Google Scholar Profile
 View ORCID Profile

Featured Publications


Cephalometric features of Class III malocclusion

– The Medical-Surgical Journal, 2015 | Citations: 48


Blended learning: The efficiency of video resources and YouTube in modern dental education

– Revista de Cercetare si Interventie Sociala, 2021 | Citations: 37


Interaction schemes for the analysis of combined action of risk factors

– E-Health and Bioengineering Conference, 2017 | Citations: 29

Elroy Patrick Weledji | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Prof. Dr. Elroy Patrick Weledji | Medicine and Dentistry | Research Excellence Award

Professor of Surgery | University of Buea | Cameroon

Dr. Elroy Patrick Weledji is a clinician–researcher at the University of Buea, Cameroon, with recognized expertise in general surgery, trauma care, and perioperative management, particularly within resource-limited settings. He has authored 62 peer-reviewed publications, receiving over 792 citations, with an h-index of 14, reflecting sustained scholarly impact. His research spans guideline implementation in colorectal surgery, appendicitis management, complex trauma and orthopedic stabilization, and clinically relevant surgical reviews, with multiple open-access contributions enhancing global knowledge dissemination. Dr. Weledji has collaborated with an extensive international network of more than 180 co-authors, demonstrating strong interdisciplinary and cross-regional engagement. His work emphasizes evidence-based practice, pragmatic surgical solutions, and health system improvement, contributing meaningfully to patient outcomes, surgical education, and the advancement of equitable healthcare delivery in low- and middle-income countries.

Citation Metrics (Scopus)

792
600
400
200
0

Citations

792

Documents

62

h-index

14

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile
 View ResearchGate Profile

Featured Publications

An Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Published on by Global Scholar Awards

Dr. Ana Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Universidad Marista, Mexico

Ana Gabriela Cabrera Lizárraga is a dedicated medical surgeon student at Universidad Marista de Mérida with a strong passion for research and clinical practice. She has actively participated in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula, focusing on genetic disorders, clinical case studies, and biomedical advancements. Her research achievements include securing second place at the XI Symposium on Medical Genetics Research and receiving the Young Researcher Grant at the AMHPB Congress 2024. With a high academic standing (GPA 93.06/100), she has also contributed to symposiums and journal clubs. Ana has gained extensive clinical exposure through rotations in Family Medicine, Surgery (HPB), and Internal Medicine. Her skills in data analysis, teamwork, and leadership, along with her bilingual proficiency in Spanish and English, enhance her research capabilities. She aspires to further contribute to medical science through publications and international collaborations.

Professional Profile 

Education

Ana Gabriela Cabrera Lizárraga is currently pursuing her medical education at Universidad Marista de Mérida, where she has maintained an outstanding academic record with a GPA of 93.06 (0-100). Her educational journey began at Colegio Mérida A.C. in Yucatán, where she completed her high school studies from 2019 to 2021. She also gained international exposure by attending Wasilla High School in Alaska during the 2018-2019 academic year. Her commitment to academic excellence is complemented by her participation in specialized courses, including the PREMED II Course at Universidad Panamericana and multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula. Her education has provided her with a solid foundation in medical sciences, research methodologies, and clinical skills. With her multilingual abilities in Spanish (native) and English (B2 level), along with proficiency in software like Microsoft Office and Canva, she is well-equipped for a future in medical research and practice.

Professional Experience

Ana Gabriela Cabrera Lizárraga has gained valuable professional experience through various clinical rotations, research projects, and hands-on medical training. She has completed rotations in Family Medicine at IMSS (UMF.52 and UMF.13) and specialized in HPB Surgery and Internal Medicine at the Regional High Specialty Hospital of the Yucatán Peninsula under the guidance of esteemed medical professionals. Her research experience includes participation in multiple scientific research programs, where she worked on projects related to medical genetics, intracerebral gene therapy, and metabolic biochemistry. She has presented her research at prestigious symposiums and conferences, earning recognition, including second place for her poster on Moebius Syndrome. Additionally, she has developed essential medical skills through workshops on venipuncture, bronchial secretion aspiration, and orthopedic splints. Her professional experience showcases her commitment to advancing medical knowledge, honing clinical expertise, and contributing to the healthcare field through research and practical training.

Research Interest

Ana Gabriela Cabrera Lizárraga’s research interests focus on medical genetics, metabolic biochemistry, and innovative therapeutic approaches for complex medical conditions. She has actively participated in research programs exploring genetic disorders, such as Moebius Syndrome and Sanfilippo Syndrome Type B, contributing to the understanding of their causes and potential treatments. Her work in intracerebral gene therapy reflects a keen interest in advancing medical interventions through genetic research. Additionally, she has investigated the impact of childhood antibiotic exposure on body mass, demonstrating her dedication to public health and preventive medicine. Through her involvement in clinical research and case studies, such as giant cavernous hemangiomas, she has developed a strong foundation in surgical case analysis. Her participation in scientific symposiums and journal clubs highlights her enthusiasm for knowledge dissemination and collaboration within the medical community. Ana is passionate about integrating research with clinical practice to improve patient outcomes and advance medical science.

Award and Honor

Ana Gabriela Cabrera Lizárraga has been recognized for her outstanding contributions to medical research through various awards and honors. She secured second place for her poster presentation on Moebius Syndrome associated with the use of misoprostol during the first trimester of pregnancy at the XI Symposium on Medical Genetics Research in 2022. Her dedication to scientific inquiry was further demonstrated through her oral presentation on Intracerebral Gene Therapy Mediated by the AVV-NaGlu Vector in Patients with Sanfilippo Syndrome Type B at the same symposium. Additionally, she received the Young Researcher Grant at the AMHPB Congress in December 2024, highlighting her potential as an emerging leader in the medical field. Ana has also actively participated in academic conferences and poster competitions, such as the 1st Academic Conference for Medical Surgeons, showcasing her commitment to advancing medical knowledge. Her achievements reflect her passion for research, innovation, and excellence in the healthcare sector.

Research Skill

Ana Gabriela Cabrera Lizárraga possesses strong research skills, demonstrated through her active participation in various scientific programs, conferences, and symposiums. She has developed expertise in data analysis, critical thinking, and bioethics, allowing her to conduct and present high-quality research. Her involvement in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula has provided her with hands-on experience in clinical research methodologies. Ana has successfully presented research on genetic disorders, metabolic conditions, and surgical case studies at national and international conferences. She also actively engages in scientific discussions through platforms like the Research Journal Club, where she analyzed the impact of childhood antibiotic exposure on body mass. Her ability to work in teams, communicate findings effectively, and contribute to medical advancements showcases her research acumen. Ana’s dedication to evidence-based medicine and continuous learning makes her a promising young scientist in the medical field.

Conclusion

Ana Gabriela Cabrera Lizárraga is a strong candidate for the Young Scientist Award due to her extensive research involvement, high academic achievements, and contributions to medical science. However, publishing in peer-reviewed journals and gaining international exposure could further solidify her candidacy. Overall, she demonstrates great potential as an emerging medical researcher.

Publications Top Noted

​Title: Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis​

Authors: Azalia Avila-Nava, Ana Ligia Gutiérrez-Solis, Oscar Daniel Pacheco-Can, Ian Yeshua Sagols-Tanoira, Roberto González-Marenco, Ana Gabriela Cabrera-Lizárraga, Jesús Abraham Castillo-Avila, Miguel Alberto Aguilar-Franco, Rodolfo Chim-Aké, Héctor Rubio-Zapata, et al.​

Year: 2025​

Citation: Avila-Nava, A., Gutiérrez-Solis, A.L., Pacheco-Can, O.D., Sagols-Tanoira, I.Y., González-Marenco, R., Cabrera-Lizárraga, A.G., Castillo-Avila, J.A., Aguilar-Franco, M.A., Chim-Aké, R., Rubio-Zapata, H., et al. (2025). Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis. Foods, 14(6), 1052. https://doi.org/10.3390/foods14061052

Mike Sabeti | Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mike Sabeti | Dentistry | Best Researcher Award

PG director at UCSF, United States

Professor Mike A. Sabeti, DDS, MA, is a distinguished clinician, researcher, and educator specializing in endodontics and periodontology. Currently serving as a Clinical Professor and Director of Post-Graduate Endodontics at UCSF, he has made significant contributions to dental education and research. With extensive experience in virology, microbiology, regeneration, and bone resorption, he has actively shaped the field through numerous editorial roles, peer-reviewed publications, and research collaborations. His dedication to academic excellence has earned him multiple awards, including the Journal of Endodontics Award (2022) and UCSF’s Excellence in Teaching Award (2019). A recognized leader, he has served as President of the Northern California Academy of Endodontics and contributed to updating vital pulp therapy guidelines. As an invited speaker at global conferences, he continues to influence the future of endodontics. His unwavering commitment to research, teaching, and clinical excellence makes him a key figure in the advancement of dental science.

Professional Profile 

Education

Professor Mike A. Sabeti, DDS, MA, has an extensive and diverse educational background in dentistry and related fields. He earned his Doctor of Dental Surgery (DDS) from the University of Texas Health Science Center at Houston (1993), laying the foundation for his career in dentistry. He further specialized by completing Advanced Education in Periodontology at Tufts School of Dental Medicine (1993-1995) and later pursued Advanced Education in Endodontics at the University of Southern California (2000-2002). In addition to his dental expertise, he holds a Master’s degree in English Literature from Prairie View A&M University (1987-1989), showcasing his broad academic interests. His commitment to excellence is reflected in his multiple professional certifications, including being board-certified by the American Board of Endodontics (2008) and holding dental licenses in both California and Texas. His strong academic foundation has paved the way for his successful career as a clinician, educator, and researcher in the field of endodontics.

Professional Experience

Professor Mike A. Sabeti, DDS, MA, has an extensive professional career spanning over three decades in endodontics, periodontology, research, and education. Currently, he serves as a Clinical Professor and Director of Post-Graduate Endodontics at UCSF, where he oversees resident training and clinical research. Previously, he held academic positions at Loma Linda University, the University of Southern California (USC), and the University of Texas at Houston, contributing significantly to dental education. He has also served as a visiting researcher in endodontics, oral maxillofacial surgery, and orthodontics at USC. Beyond academia, Dr. Sabeti has been actively involved in professional organizations, including serving as President of the Northern California Academy of Endodontics and a site visitor for the American Dental Association. With numerous international speaking engagements, editorial board memberships, and contributions to endodontic research and education, he remains a highly respected leader in the advancement of dental sciences.

Research Interest

Professor Mike A. Sabeti, DDS, MA, has a diverse and impactful research portfolio focused on advancing dental science, particularly in endodontics, periodontology, and regenerative medicine. His primary research interests include virology, microbiology, bone resorption, regeneration, and dental implants, with an emphasis on improving clinical outcomes in endodontic and periodontal treatments. As a highly active researcher and editorial board member, he has contributed to numerous peer-reviewed publications and serves as a reviewer for esteemed journals like the Journal of Endodontics and the International Endodontic Journal. His work in vital pulp therapy, bioceramics, and the perio-endo interrelationship has significantly influenced clinical practices. Additionally, he has been involved in guideline development for the American Association of Endodontics and the American Academy of Pediatric Dentistry. Through his ongoing research, international lectures, and collaborations, Dr. Sabeti continues to shape the future of endodontic science and patient care.

Award and Honor

Professor Mike A. Sabeti, DDS, MA, has received numerous prestigious awards and honors in recognition of his excellence in research, education, and clinical practice. In 2022, he was awarded the Journal of Endodontics Award by the American Association of Endodontists, highlighting his significant contributions to endodontic research. His dedication to teaching earned him UCSF’s Excellence in Teaching Award (2019) and the Faculty of the Year Award (2018) at the Community Dental Clinic. He has also been recognized for his outstanding service at the Herman Ostrow School of Dentistry at USC, receiving multiple certificates of appreciation for over a decade of contributions. Additionally, he has been named among “Best Doctors in America” (2009) and “American Top Dentists” (2003, 2006). His accolades reflect his leadership, innovation, and commitment to advancing dental education, endodontic research, and patient care on both national and international levels.

Research Skill

Professor Mike A. Sabeti, DDS, MA, possesses exceptional research skills that have contributed significantly to the fields of endodontics, periodontology, and regenerative dentistry. His expertise spans virology, microbiology, bone resorption, and biomaterials, with a strong focus on dental regeneration and implantology. As an editorial board member and peer reviewer for numerous prestigious journals, he demonstrates a keen analytical ability, critical thinking, and in-depth knowledge of current scientific advancements. His contributions include clinical trials, systematic reviews, and guideline development for organizations like the American Association of Endodontics and the American Academy of Pediatric Dentistry. Additionally, his ability to collaborate internationally, mentor postgraduate researchers, and present findings at global conferences showcases his dedication to advancing dental research. His meticulous approach to study design, data analysis, and evidence-based practice ensures that his research has a meaningful impact on clinical dentistry and patient outcomes worldwide.

Conclusion

Dr. Mike A. Sabeti is a highly accomplished academic, clinician, and researcher with a strong record of teaching, clinical supervision, and editorial contributions to the field of Endodontics. His multiple awards, leadership roles, and invited speaker engagements make him an excellent candidate for the Best Researcher Award.

To further strengthen his case, more independent primary research publications and research funding acquisitions would enhance his recognition as a leading researcher. However, based on his overall contributions to dental research, education, and professional organizations, he is undoubtedly a strong and deserving candidate for this award.

Publications Top Noted

Title: Polysaccharide-based (kappa carrageenan/carboxymethyl chitosan) nanofibrous membrane loaded with antifibrinolytic drug for rapid hemostasis – in vitro and in vivo evaluation

Authors: S.S. Salmasi, Sara Salamzadeh, M. Ehsani, Morteza, M. Zandi, Mojgan, M. Saeed, Mahdi, M. Sabeti, Mike

Journal: International Journal of Biological Macromolecules

Year: 2023

Citations: 6

Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Associate Professor at UCSF, United States

Dr. Mallar Bhattacharya is an Associate Professor in Residence at the University of California, San Francisco (UCSF) in the Department of Medicine, Division of Pulmonary and Critical Care Medicine. With an extensive academic background, he earned his A.B. in Biology and Psychology from Harvard University, an M.Sc. in Neuroscience from Oxford University, and an M.D. from Harvard Medical School. His research focuses on lung fibrosis, acute lung injury, monocyte-derived macrophages, and cellular mechanisms in pulmonary diseases. Dr. Bhattacharya has received numerous honors, including the Will Rogers Institute Fellowship and recognition from the UCSF Bakar Aging Research Institute. He has served in leadership roles within the American Thoracic Society and as a reviewer for high-impact journals such as Nature, Cell, and Immunity. Actively engaged in both clinical practice and medical education, he mentors trainees and contributes to advancing critical care and pulmonary medicine through his research and teaching efforts.

Professional Profile 

Education

Dr. Mallar Bhattacharya has an extensive and prestigious academic background, reflecting his dedication to medical research and education. He earned his A.B. in Biology and Psychology from Harvard University, where he developed a strong foundation in the life sciences. He then pursued an M.Sc. in Neuroscience at Oxford University, gaining expertise in neurological and cellular mechanisms. Continuing his medical education, he obtained his M.D. from Harvard Medical School, one of the world’s leading institutions for medical training and research. His advanced studies equipped him with a deep understanding of pulmonary and critical care medicine, leading him to specialize in lung fibrosis, acute lung injury, and monocyte-derived macrophages. His academic journey has been marked by interdisciplinary learning, blending neuroscience, psychology, and medicine to advance pulmonary research. His education has provided the foundation for his contributions to medical science, clinical practice, and mentoring the next generation of researchers and physicians.

Professional Experience

Dr. Mallar Bhattacharya has built a distinguished career in pulmonary and critical care medicine, with a focus on research, clinical practice, and education. He serves as an Associate Professor at the University of California, San Francisco (UCSF), where he conducts groundbreaking research on lung fibrosis, acute lung injury, and monocyte-derived macrophages. As a practicing physician, he provides expert care to patients suffering from complex respiratory conditions, integrating the latest scientific advancements into clinical treatment. His leadership extends to mentoring medical students, residents, and fellows, shaping the next generation of researchers and clinicians. Dr. Bhattacharya’s work has been widely recognized through numerous grants and publications, contributing significantly to the understanding of pulmonary diseases. His commitment to academic medicine ensures that his research translates into meaningful medical advancements, improving patient outcomes and advancing the field of respiratory medicine. Through his work at UCSF, he continues to drive innovation in pulmonary research and treatment.

Research Interest

Dr. Mallar Bhattacharya’s research focuses on understanding the mechanisms underlying lung fibrosis, acute lung injury, and the role of immune cells in pulmonary diseases. His work explores how monocyte-derived macrophages contribute to lung inflammation and fibrosis, aiming to uncover novel therapeutic targets for conditions such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). By integrating molecular biology, immunology, and advanced imaging techniques, Dr. Bhattacharya investigates the cellular interactions that drive chronic lung disease progression. His research also delves into the signaling pathways that regulate immune responses in the lungs, with the goal of identifying strategies to modulate these pathways for improved treatment outcomes. Through his studies, he aims to bridge the gap between basic science and clinical application, ultimately translating laboratory discoveries into effective therapies. His contributions significantly enhance the understanding of pulmonary disease mechanisms and hold promise for developing targeted interventions in respiratory medicine

Award and Honor

Dr. Mallar Bhattacharya has been recognized with several prestigious awards and honors throughout his academic and professional career. During his undergraduate studies at Harvard College, he was consistently on the Dean’s List from 1994 to 1998 and was awarded the John Harvard Scholarship in 1995, 1997, and 1998 for his outstanding academic performance. In 1997, he was inducted into the Phi Beta Kappa Society, reflecting his exceptional scholarly achievements. He also received the New York State Robert C. Byrd Honors Scholarship during his time at Harvard. In 2000, Dr. Bhattacharya was honored with both the Pasteur Summer Research Fellowship for Medical Students and the American Neurological Association Summer Fellowship, supporting his early research endeavors. Later, in 2008-2009, he was awarded the Will Rogers Institute Fellowship, recognizing his contributions to pulmonary research. These accolades underscore Dr. Bhattacharya’s commitment to excellence in research and education.

Research Skill

Dr. Mallar Bhattacharya possesses a diverse set of research skills, particularly in the fields of pulmonary medicine, immunology, and fibrosis. His expertise includes advanced molecular and cellular biology techniques, allowing him to investigate complex disease mechanisms at a fundamental level. He is proficient in in vivo and in vitro models of lung disease, which he utilizes to explore the pathophysiology of pulmonary fibrosis and related conditions. Additionally, Dr. Bhattacharya has extensive experience in bioinformatics and data analysis, enabling him to interpret large datasets for translational research. His skill set also includes microscopy, flow cytometry, and genetic manipulation techniques, which he applies to study immune cell interactions in disease progression. Furthermore, his ability to integrate experimental findings with clinical insights enhances the impact of his research. Dr. Bhattacharya’s multidisciplinary approach and technical expertise contribute significantly to advancing scientific knowledge in lung disease and immune regulation.

Conclusion

Dr. Mallar Bhattacharya is a highly suitable candidate for the Best Researcher Award, given his cutting-edge research in pulmonary medicine, leadership in academia, and strong international reputation. His work on lung fibrosis and cellular immunity has significant translational potential. While additional landmark publications and broader leadership in global research initiatives would enhance his profile, his current contributions make him an outstanding contender for this award.

Publications Top Noted

  • Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
    Authors: D Aran, AP Looney, L Liu, E Wu, V Fong, A Hsu, S Chak, RP Naikawadi, …
    Year: 2019
    Citations: 3461

  • Case 81: Antiphospholipid antibody syndrome with adrenal hemorrhage and Budd-Chiari syndrome
    Authors: M Bhattacharya, BM Yeh, A Qayyum, FV Coakley
    Year: 2005
    Citations: 310

  • Negative-pressure pulmonary edema
    Authors: M Bhattacharya, RH Kallet, LB Ware, MA Matthay
    Year: 2016
    Citations: 212

  • Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
    Authors: WB Eubank, D Mankoff, M Bhattacharya, J Gralow, H Linden, G Ellis, …
    Year: 2004
    Citations: 172

  • Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation
    Authors: G Su, A Atakilit, JT Li, N Wu, M Bhattacharya, J Zhu, JE Shieh, E Li, …
    Year: 2012
    Citations: 100

  • Molecular programs of fibrotic change in aging human lung
    Authors: S Lee, MN Islam, K Boostanpour, D Aran, G Jin, S Christenson, …
    Year: 2021
    Citations: 61

  • Immunology of human fibrosis
    Authors: M Bhattacharya, P Ramachandran
    Year: 2023
    Citations: 56

  • Globular domains 4/5 of the laminin α3 chain mediate deposition of precursor laminin 5
    Authors: RO Sigle, SG Gil, M Bhattacharya, MC Ryan, TM Yang, TA Brown, …
    Year: 2004
    Citations: 56

  • Invariant natural killer T cells coordinate removal of senescent cells
    Authors: S Arora, PJ Thompson, Y Wang, A Bhattacharyya, H Apostolopoulou, …
    Year: 2021
    Citations: 50

  • Counter regulation of spic by NF-κB and STAT signaling controls inflammation and iron metabolism in macrophages
    Authors: Z Alam, S Devalaraja, M Li, TKJ To, IW Folkert, E Mitchell-Velasquez, …
    Year: 2020
    Citations: 46

  • Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5
    Authors: G Su, A Atakilit, JT Li, N Wu, J Luong, R Chen, M Bhattacharya, …
    Year: 2013
    Citations: 37

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

Published on by Global Scholar Awards

Dr. Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

CEO at CEFO, South Korea

Dr. Hyun-Sook Park is an accomplished researcher and leader in the fields of stem cell science, tissue engineering, and regenerative medicine. She holds a Ph.D. in Pathology from Imperial College London, where she focused on adult stem cells in the gastrointestinal tract. As the CEO of CEFO Bio Co., Ltd, Dr. Park has spearheaded innovations in stem cell therapies and bioengineering, with significant contributions to skin regeneration and pancreatic beta-cell differentiation. Her academic career includes roles as an affiliated professor at prestigious Korean universities. Dr. Park has held key leadership positions, including serving on boards for the Korea Society of Stem Cell Research and the Korean Tissue Engineering & Regenerative Medicine. She has received numerous awards, such as the British Council Ph.D. Award and Digital Innovation Award, recognizing her groundbreaking research. Dr. Park is also actively involved in shaping national policy on biomedical sciences and advancing global research initiatives.

Professional Profile

Education

Dr. Hyun-Sook Park has a distinguished academic background, with degrees from prestigious institutions. She earned her Bachelor of Science in Biology from Korea University in Seoul (1982-1986), followed by a Master of Science in Zoology from the same university (1986-1988). Dr. Park then pursued a Ph.D. in Pathology at Imperial College London, where she focused on adult stem cells in the gastrointestinal tract and their role in cancer development and regeneration. She completed her Ph.D. under the supervision of Dr. Nicholas A. Wright in 1997, at the Imperial College School of Medicine. Her research at Imperial College, specifically on gastrointestinal epithelial stem cells, marked the beginning of her long-standing interest in stem cell science. This educational foundation laid the groundwork for her future groundbreaking contributions to stem cell research, tissue engineering, and regenerative medicine, establishing her as a leader in the biomedical field.

Professional Experience

Dr. Hyun-Sook Park has an extensive professional career in biomedical research and leadership. She is the CEO of CEFO Bio Co., Ltd, where she oversees the company’s innovative work in stem cell therapies and bioengineering. Dr. Park’s research experience spans several prestigious institutions. She served as Vice Director at BioSolution (2007-2011), focusing on human embryonic stem cells and skin regeneration. Prior to this, she was Director of the Research Institute at MizMedi Hospital Medical Research Center (2005-2007), where she studied stem cell differentiation. Dr. Park also worked as a Senior Research Scientist at the Institute of Radiological and Medical Sciences (1999-2005), specializing in tissue engineering and pancreatic beta-cell differentiation. She has held postdoctoral roles, including at the Korea Research Institute of Bioscience and Biotechnology, and was a visiting researcher at the Imperial Cancer Research Fund. Her career has also included advisory roles and leadership in scientific committees and organizations.

Research Interests

Dr. Hyun-Sook Park’s research interests are centered around stem cell science, tissue engineering, and regenerative medicine. Her early work focused on adult stem cells in the gastrointestinal tract, exploring their role in cancer development and tissue regeneration. Over the years, she expanded her research to encompass a range of biomedical applications, including human embryonic stem cell differentiation, specifically in endodermal and mesodermal lineages. Dr. Park has made significant contributions to the development of bioartificial tissues, such as skin regeneration, and the differentiation of pancreatic beta cells from stem cells for potential diabetes treatments. Her research also explores gene therapy and the use of stem cells in cancer therapies. More recently, she has been involved in advanced techniques, such as the use of ultra-sensitive nanoparticles for tracking endothelial cells. Dr. Park’s work is crucial in advancing regenerative medicine and tissue engineering, with the potential to revolutionize treatments for various diseases.

Awards and Honors

Dr. Hyun-Sook Park has received numerous prestigious awards and honors throughout her career, recognizing her exceptional contributions to scientific research and innovation. Among her accolades is the British Council Ph.D. Award (1990) for her outstanding academic achievements. She also received the Digital Innovation Award in 2014 and 2017, acknowledging her pioneering work in stem cell research and regenerative medicine. Dr. Park was awarded the Overseas Research Scholarship Award (1990-1993) and the Weston Scholarship in the Royal Postgraduate Medical School (1990-1993), which supported her studies at Imperial College London. In addition to these awards, Dr. Park’s research has been consistently recognized by the scientific community, reflected in her extensive publication record and involvement in high-impact projects. Her leadership in the field is further highlighted by her membership in influential committees and advisory roles, shaping national policies in biomedical research. These honors underscore her significant impact on science and healthcare advancements.

Conclusion

Dr. Hyun-Sook Park is an outstanding candidate for the Women Researcher Award. With her exemplary leadership in bioengineering and stem cell research, she has made tremendous contributions to the scientific community. Her innovations in regenerative medicine and cancer research, along with her leadership in key professional and governmental committees, underline her profound impact on both science and policy. While there are opportunities for her to increase her global visibility and outreach, her achievements clearly demonstrate the caliber of a distinguished researcher deserving of this prestigious award.

Publications Top Noted

  • Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
    • Authors: Baek, S.-H., Shim, B.-J., Won, H., Park, H.S., Kim, S.-Y.
    • Year: 2024
    • Citations: 0
  • Early Osteogenic-Induced Adipose-Derived Stem Cells and Canine Bone Regeneration Potential Analyzed Using Biodegradable Scaffolds
    • Authors: Yun, H.-H., Kim, S.-G., Park, S.-I., Hong, I.-H., Jeong, K.-S.
    • Year: 2023
    • Citations: 2
  • In Vitro Tracking of Human Umbilical Vein Endothelial Cells Using Ultra-Sensitive Quantum Dot-Embedded Silica Nanoparticles
    • Authors: Kim, J., Lee, S., Lee, Y.K., Jun, B.-H., Park, H.-S.
    • Year: 2023
    • Citations: 6
  • Comparison of Temperature Equilibrium Rate and Cell Growth/Viability Under Air Circulation in Cryogenic Storage Container
    • Authors: Park, J.-Y., Lee, D.-W., Lee, S., Park, H.-S., Yoon, G.-S.
    • Year: 2022
    • Citations: 0
  • Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells
    • Authors: Suh, D.H., Lee, S., Park, H.-S., Park, N.H.
    • Year: 2020
    • Citations: 4
  • Differentiation of Equine Induced Pluripotent Stem Cells into Mesenchymal Lineage for Therapeutic Use
    • Authors: Chung, M.-J., Park, S., Son, J.-Y., Park, H.-S., Jeong, K.-S.
    • Year: 2019
    • Citations: 19
  • Establishment of Stably Expandable Induced Myogenic Stem Cells by Four Transcription Factors
    • Authors: Lee, E.-J., Kim, M., Kim, Y.D., Hwang, D., Jeong, K.-S.
    • Year: 2018
    • Citations: 15
  • Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and Their Differentiated Derivatives
    • Authors: Nazor, K.L., Altun, G., Lynch, C., Loring, J.F., Laurent, L.C.
    • Year: 2012
    • Citations: 316
  • The Effects of the Physical Properties of Culture Substrates on the Growth and Differentiation of Human Embryonic Stem Cells
    • Authors: Lee, S., Kim, J., Park, T.J., Kang, S., Park, H.-S.
    • Year: 2011
    • Citations: 29
  • Comparison of Mesenchymal-like Stem/Progenitor Cells Derived from Supernumerary Teeth with Stem Cells from Human Exfoliated Deciduous Teeth
    • Authors: Lee, S., An, S., Kang, T.H., Kwak, C.K., Park, H.-S.
    • Year: 2011
    • Citations: 29

Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Doctoral student at Shanghai Ruijin Hospital, China

Dr. Pengyi Liu is a dedicated researcher specializing in the tumor immune microenvironment of pancreatic cancer. Currently pursuing a doctoral degree at Ruijin Hospital, Shanghai Jiaotong University, Liu’s work focuses on understanding the roles of macrophages and T cells in tumor progression. With a Bachelor’s degree in Clinical Medicine, Liu has consistently excelled academically, earning numerous honors, including multiple scholarships and recognition as an “Outstanding Graduate.” Their research has led to significant publications in high-impact journals, exploring novel mechanisms in pancreatic cancer, such as macrophage differentiation and immune response modulation. Proficient in various experimental techniques like cell culture, flow cytometry, and molecular biology, Liu demonstrates a broad skill set essential for cutting-edge cancer research. Their collaborative efforts and innovative approaches continue to advance the field, offering potential new targets for diagnosis and treatment. Liu’s work holds promise for improving clinical outcomes in pancreatic cancer patients.

Professional Profile

Education

Dr. Pengyi Liu’s educational journey reflects a strong foundation in clinical medicine and research. He completed his Bachelor’s degree in Clinical Medicine at Shanghai Jiaotong University from 2016 to 2021, achieving a commendable GPA of 3.63. During this time, Liu was recognized for his academic excellence, earning multiple scholarships and being named a “Merit Student” in 2020. After completing his undergraduate studies, Liu continued his education at Ruijin Hospital, affiliated with Shanghai Jiaotong University School of Medicine, where he is currently pursuing a Doctor of Surgery degree under the prestigious “Zhiyuan Honors Program.” His research is guided by Prof. Baiyong Shen, focusing on the molecular mechanisms of pancreatic cancer. In addition to his rigorous academic training, Liu has taken a wide range of courses, including Anatomy, Physiology, Molecular Biology, Immunology, and Laboratory Animal Science, providing him with a well-rounded knowledge base for his advanced research.

Professional Experience

Dr. Pengyi Liu’s professional experience is centered around groundbreaking research in the field of pancreatic cancer. Currently a doctoral candidate at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Liu is engaged in advanced research on the tumor immune microenvironment, particularly the roles of macrophages and T cells in tumor progression. Under the mentorship of Prof. Baiyong Shen, Liu has contributed to numerous high-impact publications on pancreatic cancer, including studies on macrophage differentiation, immune modulation, and tumor progression. His research projects are multifaceted, encompassing both molecular and animal model-based approaches to uncover novel mechanisms and potential therapeutic targets. Liu is proficient in various laboratory techniques, including cell culture, flow cytometry, molecular biology assays, and the construction of patient-derived xenograft and organoid models. His work continues to shape the understanding of pancreatic cancer, offering new insights into its diagnosis, treatment, and the development of targeted therapies.

Research Interests

Dr. Pengyi Liu’s research interests are centered around the tumor immune microenvironment, with a particular focus on pancreatic cancer. His work aims to understand the complex interactions between immune cells, such as macrophages and T cells, and tumor progression. Liu is dedicated to uncovering the molecular mechanisms that drive pancreatic cancer, especially how immune cells contribute to the tumor environment and influence cancer growth. His research explores the roles of various molecules, including lncRNAs and signaling pathways, in shaping the immune response and tumor microenvironment. By studying the molecular and cellular processes in pancreatic cancer, Liu aims to identify potential therapeutic targets for better diagnosis and treatment strategies. Additionally, Liu’s work involves the development and use of advanced experimental models, such as patient-derived xenografts and organoids, to simulate the tumor environment and test new treatment approaches. His goal is to bridge the gap between basic research and clinical application in oncology.

Awards and Honors

Dr. Pengyi Liu has received numerous awards and honors throughout his academic career, reflecting his exceptional performance and dedication to research. He was awarded the prestigious scholarships of Shanghai Jiaotong University in 2017, 2018, 2019, and 2020, which recognize his academic excellence. In 2020, he was named a “Merit Student,” further highlighting his outstanding achievements. Dr. Liu’s dedication to his studies was also acknowledged when he was recognized as an “Outstanding Graduate” in 2021, a testament to his strong academic record and research contributions. Additionally, as a graduate student, he was awarded the First-Class Scholarship in 2022 and the Second-Class Scholarship in 2023, underscoring his continued academic excellence and research productivity. These accolades demonstrate not only his commitment to excellence but also the recognition he has earned from his peers and academic community for his hard work and significant contributions to the field of medical research.

Conclusion

Pengyi Liu’s academic achievements, extensive research experience, and significant contributions to understanding the tumor immune microenvironment in pancreatic cancer make them a strong contender for the Best Researcher Award. With a clear focus on advancing scientific knowledge and potential for real-world impact, Liu exemplifies the qualities of a leading researcher. Continued diversification of their research scope and greater emphasis on clinical applications could further amplify their contributions to the field.

Publications Top Noted

  1. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, P., Sun, K., Wang, T., Shen, B.
    • Year: 2024
    • Journal: Cancer Cell International
    • Citations: 0
  2. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
    • Authors: Chen, D., Liu, P., Lu, X., Li, H., Shen, B.
    • Year: 2024
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  3. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
    • Authors: Liu, Y., Cao, Y., Liu, P., Wang, W., Shen, B.
    • Year: 2024
    • Journal: Cellular Oncology
    • Citations: 2
  4. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    • Authors: Cao, Y., Wang, X., Liu, Y., Jiang, L., Shen, B.
    • Year: 2024
    • Journal: Advanced Science
    • Citations: 3
  5. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization
    • Authors: Liu, Y., Liu, P., Duan, S., Jiang, Y., Shen, B.
    • Year: 2024
    • Journal: Cell Death and Differentiation
    • Citations: 0
  6. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, Y., Liu, P., Bao, H., Lin, J.
    • Year: 2023
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  7. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer
    • Authors: Zhai, S., Lin, J., Ji, Y., Deng, X., Shen, B.
    • Year: 2023
    • Journal: Cell Discovery
    • Citations: 10
  8. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
    • Authors: Wang, L., Liu, Y., Dai, Y., Chen, S., Shen, B.
    • Year: 2023
    • Journal: Gut
    • Citations: 100
  9. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
    • Authors: Liu, Y., Shi, M., He, X., Sun, B., Shen, B.
    • Year: 2022
    • Journal: Journal of Hematology and Oncology
    • Citations: 76

Tingting Gao | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Tingting Gao | Medicine and Dentistry | Best Researcher Award

Doctor at Shanxi medical university, China

Dr. Tingting Gao is a dedicated and accomplished medical researcher with a strong focus on vascular surgery, immunometabolomics, and multimodal molecular imaging. She is currently pursuing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, where she works under the guidance of Professor Honglin Dong. With a broad range of research interests and expertise in cutting-edge imaging technologies, Dr. Gao has made significant contributions to the understanding of vascular diseases, atherosclerosis, and kidney injury. Her work bridges the gap between experimental biology and clinical applications, demonstrating a commitment to advancing both basic and translational research.

Professional Profile

Education

Dr. Tingting Gao is currently completing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, Taiyuan, China. She has been under the academic mentorship of Dr. Honglin Dong, MD, Ph.D., Assistant Dean of The Second Hospital of Shanxi Medical University. Her education has provided her with a strong foundation in both medical practice and research, allowing her to contribute to the field of vascular surgery while pursuing advanced studies in molecular medicine and disease mechanisms. Her educational journey emphasizes her dedication to both scientific inquiry and clinical expertise.

Professional Experience

Dr. Gao’s professional experience includes significant roles as a Research Assistant in the Department of Vascular Surgery at The Second Hospital of Shanxi Medical University, where she has worked from 2023 to the present. In this role, she conducts research focused on immunometabolomics and multimodal molecular imaging of vascular diseases. She has also worked as a subject participant in various research projects, such as the study of aortic aneurysms and contrast-induced acute kidney injury. Additionally, Dr. Gao has extensive clinical experience in vascular surgery, having worked from 2018 to 2022 in the same hospital, gaining hands-on expertise in patient care and surgical procedures.

Research Interests

Dr. Gao’s research interests span several domains, including vascular surgery, atherosclerosis, liver disease, and imaging technologies. She is particularly interested in the mechanisms underlying vascular diseases, such as atherosclerosis, and how substances like garlic can impact these conditions. Her work integrates network pharmacology, bioinformatics, and experimental verification to explore therapeutic pathways like ferroptosis. Additionally, she focuses on advanced imaging techniques, such as photoacoustic microscopy and magnetic nanoparticle imaging, to better understand disease mechanisms and improve diagnostic tools. Her multidisciplinary approach blends laboratory research with clinical applications, aiming to make a significant impact in both fields.

Awards and Honors

Dr. Gao has received recognition for her research contributions through various awards and honors. She has been a part of multiple funded projects, including those by the Shanxi Provincial Science and Technology Department and the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi Province. These grants have supported her participation in cutting-edge research exploring vascular diseases, kidney injury, and novel imaging technologies. Dr. Gao’s dedication to her field has also been acknowledged by her peers, reflected in her impressive publication record and active participation in international conferences, where she has presented her findings at major forums like the World Molecular Imaging Society.

Conclusion

The individual appears highly deserving of the Best Researcher Award due to their comprehensive academic background, impressive publication record, technical expertise, and contributions to advanced research in vascular diseases, imaging technologies, and pharmacology. They have demonstrated creativity and leadership in scientific exploration, with innovative work that holds significant potential for clinical applications. However, future opportunities for growth could include assuming more independent leadership roles, increasing international recognition, and further advancing the clinical impact of their research.

Publications Top Noted

  1. Title: Highly sensitive magnetic particle imaging of abdominal aortic aneurysm NETosis with anti-Ly6G iron oxide nanoparticles
    Authors: Wang, H., Zhang, R., Jia, X., Hui, H., Dong, H.
    Year: 2024
    Citations: 0
  2. Title: Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study
    Authors: Gao, S., Gao, T., Li, L., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  3. Title: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
    Authors: Wang, H., Tian, Q., Zhang, R., Zheng, G., Dong, H.
    Year: 2024
    Citations: 2
  4. Title: The Protective Role of Intermedin in Contrast-Induced Acute Kidney Injury: Enhancing Peritubular Capillary Endothelial Cell Adhesion and Integrity Through the cAMP/Rac1 Pathway
    Authors: Gao, T., Gu, R., Wang, H., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  5. Title: The Down-Shifting Luminescence of Rare-Earth Nanoparticles for Multimodal Imaging and Photothermal Therapy of Breast Cancer
    Authors: Gao, T., Gao, S., Li, Y., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  6. Title: Case Report: The application of novel imaging technologies in lower extremity peripheral artery disease: NIR-II imaging, OCTA, and LSFG
    Authors: Ning, Y., Hu, J., Li, H., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  7. Title: Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
    Authors: Gao, T., Gao, S., Wang, H., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  8. Title: Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms
    Authors: Cheng, X., Zhang, R., Qi, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  9. Title: High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis
    Authors: Zhang, R., Wang, H., Cheng, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  10. Title: Neutrophil Extracellular Traps Aggravate Contrast-Induced Acute Kidney Injury by Damaging Glomeruli and Peritubular Capillaries
    Authors: Wang, H., Gao, T., Zhang, R., Zheng, G., Dong, H.
    Year: 2023
    Citations: 5